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PreviewsThe current findings in the mouse
appear relevant for human T-ALL. The
(partial) loss of Tcf1 is now also reported
in a subset of pediatric T-ALL, the ETP
group, in which deletions of TCF7 were
found in two patients (Yu et al., 2012).
MEF2C has recently been shown to act
as the master transcriptional regulator of
genes that constitute the signature of
ETP-ALL (Homminga et al., 2011). Inter-
estingly, gene expression profiling of
Tcf7/ lymphomas shows upregulated
expression of Mef2c(Tiemessen et al.,
2012), further supporting the possibility
that lack of Tcf1 may be involved in
development of certain ETP-ALL cases.
The unexpected finding that Tcf1 is
a tumor suppressor gene also indicates
that Tcf1 and Lef1 are not merely redun-
dant in the thymus. For normal T cell
development, a deficiency in both Lef1
and Tcf1 results in a more profound
arrest in thymocyte differentiation than
seen with Tcf1 alone (Yu et al., 2012), indi-
cating a redundant role of these two
factors. However, for the development of
T cell lymphomas, Lef1 is the culprit
leading to cellular transformation,
whereas Tcf1 can function as transcrip-
tional repressor of Lef1, in the role of
a classical tumor suppressor gene. How
this dichotomous cooperative althoughantagonistic relationship between these
two DNA-binding factors is regulated
and if Wnt signaling plays a role in this
regulation is currently not understood
(Figure 1, bottom).
Tcf1 has been shown to act as
commitment factor for the T cell lineage
in hematopoietic stem cells in gain-of-
function experiments (Weber et al.,
2011), a finding that was not corrobo-
rated by the loss-of-function experiments
reported by Yu et al. (2012). This may
indicate that yet another Tcf related
factor, for instance Tcf4, can partially
compensate for loss of both Tcf1 and
Lef1, because inhibition of canonical
Wnt signaling blocks thymopoiesis at
DN1. Whether the dual roles that Tcf1
plays in T cell development are intrinsi-
cally different from the roles of Lef1 or
merely determined by stoichiometry and
abundance of various splice variants
(in different lineages or developmental
stages) remains to be determined.
Nevertheless, the T cell-specific tumor
suppressor function of Tcf1 that is best
known as an activator of the Wnt path-
way is an unexpected twist.REFERENCES
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In this issue of Immunity, Yu et al. (2012) outline a fascinating model in which TLR7-mediated antibody
production acts as a dominant immunosurveillance mechanism against endogenous retroviruses (ERVs),
with additional support of TLR3 and TLR9 that function to prevent ERV-mediated malignancy.Our innate immune system has evolved
several pattern recognition receptors
(PRRs) to sense microbial nucleic
acids. A prominent group of these PRRs
constitutes the subfamily of Toll-like
receptors (TLRs) that has evolved tosense ssRNA and short dsRNA (TLR7,
TLR8), DNA (TLR9), or long dsRNA
(TLR3). Upon ligand recognition, TLR
activation sets off signaling cascades
that are geared toward the eradication
of the microbial pathogen, ranging fromthe activation of immediate effector
functions to the initiation of adaptive
immune responses (Kawai and Akira,
2011).
A large proportion of the mammalian
genome is made up of fossils ofovember 16, 2012 ª2012 Elsevier Inc. 763
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Previewstransposable elements and amajor part of
these remnants are derived from endoge-
nous retroviruses (ERVs) (Stocking and
Kozak, 2008; Stoye, 2012). ERVs are the
result of exogenous retroviruses (XRVs)
that have integrated within the germline
of the host, thereby subjecting the
provirus to mendelian inheritance. Most
ERVs have lost their capability to propa-
gate because of numerous inactivating
mutations, yet a considerable number of
active ERVs has been documented in
the murine system (Stoye, 2012). Among
these, the best-studied ERVs can be
found within the class I ERVs that are
closely related to the gamma retrovirus
genus of XRVs, typified by murine
leukemia viruses (MuLVs). MuLVs are
well known for their ability to induce onco-
genic transformation leading to leukemia
in mice and as such they have been
studied extensively. Germline-encoded
provirus, with the potential of giving rise
to infectious MuLVs with ecotropic host
range, are found in low copy number in
various inbred mouse strains, and the
commonly used laboratory strain C57BL/
6 harbors the provirus of a defective
endogenous ecotropic MuLV (E-MuLV)
on chromosome 8 (Emv2). Emv2 harbors
a point mutation in its pol region that
prevents its propagation a priori. In addi-
tion, its so-called N-tropism encoded in
its gag region would restrict its growth in
C57BL/6 mice that express the allele
combination Fv-1b/b, which encodes for
a restriction factor for N-tropic viruses
(Stocking and Kozak, 2008). Mechanisti-
cally, Emv2 reactivation is most probably
due to in trans complementation of its
defects by nonecotropic ERVs, an event
that can be triggered by genetic (cross-
breeding) or environmental (e.g., inflam-
mation) factors (Greenberger et al.,
1975;McCubrey and Risser, 1982). None-
theless, under normal conditions inbred
C57BL/6 mice do not display E-MuLV
viremia that would lead to disease
pathology. Next to dedicated restriction
factors that prevent propagation of
endogenous and exogenous MuLVs in
a cell-intrinsic fashion (Stoye, 2012), it
has been shown that exogenous MuLV
infection in ERV-negative inbred mouse
strains is effectively controlled by
a TLR7-dependent antibody response
(Browne, 2011; Kane et al., 2011).
In order to dissect the exact role of
the three nucleic acid-sensing TLRs, Yu764 Immunity 37, November 16, 2012 ª2012et al. (2012) generated mice deficient in
these TLRs. Unexpectedly, they found
that aged Tlr3/Tlr7/Tlr9/ mice
were overtly sick and died earlier when
compared to the age-matched wild-type
controls. Autopsy of diseased animals
showed enlarged thymus and secondary
lymphoid organs and histology revealed
a pre-T cell acute lymphoblastic lym-
phoma (T-ALL). Microarray analysis of
splenic tissue in Tlr3/Tlr7/Tlr9/
mice showed a dramatic upregulation of
endogenous retroviral sequences, the
presence of which was confirmed by
the visualization of the budding viruses
from the thymic tissue. To identify the
contribution of the individual endosomal
TLRs to this phenotype, Yu et al. (2012)
checked for active ERVs in different
single and compound mutant mice.
Tlr7/ and compound mutant mice
where TLR7 was also deleted showed
significant increase in ERV mRNA and
protein expression. However, no evi-
dence of ERV viremia was observed in
Tlr3/, Tlr9/, or Tlr3/Tlr9/ mice,
indicating that absence of TLR7 alone
was sufficient and necessary for the virus
to propagate. In line with this notion, mice
deficient in upstream or downstream
components of the TLR7 signaling
cascade also displayed increased retro-
viral gene expression. However, whereas
TLR7 deficiency led to retroviremia in
these mice, only Tlr3/Tlr7/Tlr9/
animals displayed T-ALLs. Subsequent
studies indicated that none of the T cell
populations within the thymus showed
significant endosomal TLR expression,
yet the cortical thymic epithelial cells
and plasmacytoid dendritic cells ex-
pressed them, suggesting that TLR-
mediated protection against ERV pro-
pagation operates in a cell-extrinsic
manner.
The pol region within retroviral RNAs
from T-ALL lines revealed strong
homology to the endogenous Emv2
provirus, with a correction of its mutation.
This is highly indicative of recombina-
tion events between Emv2 and one or
more nonecotropic viruses subsequently
giving rise to a replication competent
retrovirus. Studying ERV integration at
the genomic level, the authors observed
that Tlr3/Tlr7/Tlr9/ mice displayed
multiple integrations events in lymphoid
tissue and most prominently in tumor
cell clones. Surprisingly, yet in line withElsevier Inc.the tumor data, only Tlr3/Tlr7/Tlr9/
mice, but no other ERV viremic mice
(e.g., Tlr7/), showed additional proviral
integrations at the genomic level, at least
when using Southern blot to probe for
such events. A common driver in retro-
virus-mediated oncogenesis is the
activation of proto-oncogenes by the
integration of proviral DNA in vicinity to
these genes. In line with this, the authors
observed frequent genomic ERV reinte-
gration events within proximity to coding
sequences of proto-oncogenes in T-ALL
cell lines of Tlr3/Tlr7/Tlr9/ mice.
Analyzing the serum from different
genotypes for the presence of anti-ERV-
specific IgGantibodies revealedan inverse
picture as compared to the ERV expres-
sion data. Mice devoid of active ERVs dis-
played high amounts of anti-ERV-specific
IgG antibodies, and these antibodies
were also able to inhibit the replication of
an exogenous MuLV in vitro. Interestingly,
despite comparable titers, anti-ERV serum
from wild-type mice showed the highest
inhibitory activity, whereas serum from
Tlr3/, Tlr9/, or Tlr3/Tlr9/ mice
was less effective.
Yu et al. (2012) suggest that de novo
ERV reactivation occurs spontaneously
in wild-type C57BL/6 mice (Figure 1). The
exact location, timing, and mechanism of
this reactivation is unclear, yet its occur-
rence is unequivocally documented by
the high and specific class-switched ERV
antibody titers. This is in line with early
studies that have reported the phenom-
enon of ‘‘autogenous’’ anti-ERV immunity
in inbred mouse strains in the absence of
retroviremia (Hanna et al., 1972). The fact
that TLR7 plays a nonredundant role in
the induction of protective antibody titers
in response to ERV reactivation is
intriguing, yet not unexpected given
previous studies exploring the role of
TLR7 in adaptive immune responses
toward XRVs (Browne, 2011; Kane et al.,
2011). However, Yu et al. (2012) refine
and extend this concept by demonstrat-
ing a nonredundant role for TLR7 in
the immunosurveillance of endogenous
retroviruses. Extrapolating results from
studies with exogenous MuLVs predicts
that B cell-intrinsic TLR7 activation is
instrumental for this protection (Browne,
2011).
Theoretically, loss of TLR7 signaling
could also be positioned upstream of the
observed ERV reactivation event through
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Figure 1. A Schematic View of the Role for TLR3, TLR7, TLR9 in Controlling Endogenous
Retroviruses
(i) Through yet unknown mechanisms, the C57BL/6 ERV provirus Emv2 is reactivated, most probably
resulting from a complementation event in trans by nonecotropic ERVs. Environmental factors could
play an important modulatory role in this process. (ii) ERVs activate TLR7 in B cells and/or dendritic cells,
leading to an adaptive immune response that results in the production of high ERV antibody titers that
function to neutralize and control ERVs. (iii) The absence of TLR7 or TLR7 signaling results in the loss of
protective ERV antibodies and subsequently in retroviremia, yet this is kept in check by TLR3- and
TLR9-dependent mechanisms. (iv) Possible effector mechanisms that are governed by TLR3 and TLR9
could be activation of cytotoxic CD8+ T cells, or CD4+ T cells and/or NK cells that eradicate retrovirally
infected cells.
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Previewsan indirect mechanism that is unrelated
to the role of TLR7 in orchestrating
the antiretroviral antibody response.
However, this scenario appears less likely
given the well-documented role of TLR7
in directing antiretroviral immunity and
the strict inverse correlation of ERV-
specific antibody titers and viremia as
a function of TLR7 expression. Neverthe-
less, it has to be considered that
a dysfunctional TLR7 axis and more so
a complete lack in nucleic acid-sensing
TLRs could also have an impact on
the reactivation and propagation of the
ERVs themselves, independently of the
specific anti-ERV response. Indeed, it is
conceivable that Tlr3/Tlr7/Tlr9/
animals display a dysfunctional immune
system that could lead to secondaryevents facilitating the reactivation of
ERVs. Indeed, in a recent study by Young
et al. (2012), the lack of functional B cell
immunity was also identified as a critical
component for ERV reactivation.
However, Young et al. (2012) positioned
lack of antibody production upstream
of ERV reactivation rather than func-
tioning as an endogenous ERV surveil-
lance mechanism. More specifically, a
dysregulation of the intestinal microbiome
in the absence of B cell immunity was
suggested to trigger inflammation leading
to ERV reactivation. Further studieswill be
required to reconcile these two models.
Another intriguing finding is that
only the additional absence of TLR3
and TLR9 results in tumorigenesis in
ERV-viremic, TLR7-deficient animals.Immunity 37, NThe authors suggest that this could be
due to a qualitative difference in the
adaptive immune response of the host.
Indeed, neutralization experiments with
sera from wild-type versus Tlr3/,
Tlr9/, or Tlr3/Tlr9/ mice alludes to
a qualitative difference of the anti-ERV
sera. Moreover, the different repertoire
of antigens being recognized by these
sera points into the same direction. As
such, it is possible that T cell help
provided indirectly by TLR3 and TLR9
activation drives the formation of a more
effective antibody repertoire. Another
likely scenario is that TLR3 and TLR9
could be instrumental for the initiation
of cytotoxic CD8+ T cell responses,
a phenomenon that is known to be inde-
pendent of TLR7 in the context of exoge-
nous MuLV infection (Browne, 2011).
TLR3, for example, plays an important
role in cross priming antigen-specific
CD8+ T cells and it is possible that this
mechanism accounts for the induction
of cytotoxic T cell responses eliminating
transformed T cells. At the same time,
it should also be considered that the
additional absence of TLR3 and/or TLR9
could indirectly shape a different MuLV
‘‘repertoire,’’ which could lead to the
observed malignant transformation. In
this respect, it would be very informative
to obtain full sequences of the ERV
repertoire arising in the different gene-
deleted mouse strains.
In summary, Yu et al. (2012) unravel
a pivotal role for nucleic acid-sensing
TLRs in the immunosurveillance of en-
dogenous retroviruses, with TLR7 playing
a dominant role in inhibiting ERV viremia
in the first place and TLR3 and TLR9
playing a secondary but significant role
in preventing retroviral-induced malig-
nancy. In the absence of clear evidence
showing a role for ERVs in human
diseases, it remains speculative whether
similar protective mechanisms are at
play in the human system and how they
impact disease. Nevertheless, primed by
this study we may now be looking for
a possible protective role for ERV immu-
nosurveillance in humans.REFERENCES
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It is unclear how the Langerhans cell (LC) network is maintained in adult epidermis. In this issue of Immunity,
Sere´ et al. (2012) show that LCs are replenished in two waves. Monocyte-derived, short-lived LCs come first.
A second wave follows, and these LCs of nonmonocytic origin are long-lived.Langerhans cells (LCs) are dendritic
cells of epithelia. The best-studied ex-
ample is LCs of the epidermis (Romani
et al., 2010). From the early experiments,
it has been appreciated that there is
something special about the life cycle of
epidermal LCs. When human skin was
transplanted onto nude mice, human
LCs within the graft persisted for a
remarkably long period of several months
(Krueger et al., 1983). Studies from others
have corroborated these observations
(Merad et al., 2002). It was established
that (1) LCs populate the epidermis early
in ontogeny and (2) they are very long-
lived. The LCnetwork is establishedwithin
a few days after birth by an initial burst of
proliferation as demonstrated in murine
epidermis (Chorro et al., 2009). In human
skin, precursors of LC are present in the
embryonic skin, and they gradually
acquire LC-specific markers during
development of the fetus (Schuster et al.,
2009). With regard to longevity, LCs
essentially persist for the entire lifetime
of a mouse, provided the epidermis is
not disturbed by inflammation. Even in
human hand transplants, the LCs of the
hand donor remained in place for almost
a decade (Kanitakis et al., 2011).
From this body of evidence, one could
infer that LCs in the steady-state adultepidermis are a largely independent cell
population that renews itself and does
not need fresh supplies from progenitor
cells in bone marrow or the dermis. In
contrast, another nonembryonic LC pre-
cursor cell has been reported (Ginhoux
et al., 2006). During skin inflammation
induced by UV-C irradiation, which largely
depletes resident LCs from the epidermis,
LCs are subsequently replenished by
immigrating monocytes that are charac-
terized by the expression of the Gr-1
marker. Once in the epidermis, mono-
cytes acquire langerin (also known as
CD207) expression.
In spite of the seminal findings
mentioned above, the homeostasis of
LCs in the adult epidermis is still not
entirely clear. Can monocytic LC pre-
cursors fully make up for the inflamma-
tion-induced lack of LCs? Do these
‘‘monocyte-derived LCs’’ in the epidermis
live equally long (i.e., virtually life-long) as
the ‘‘normal’’ LCs that populated the
epidermis around birth? How exactly is
the epidermis reconstituted with LCs after
an inflammation-induced efflux of LCs? In
this issue of Immunity, Sere´ et al. (2012)
made use of mice with deleted transcrip-
tion factor Id2, which strikingly lack all
LCs (Hacker et al., 2003) and langerin+
dermal dendritic cells. Thus, the miceare devoid of any langerin-expressing
cells in the skin. When wild-type (WT)
bone marrow was injected into these
adult Id2-deficient mice, a network of
LCs established over time, suggesting
that the repopulation in the steady-state
occurred by bone marrow-derived
precursors that acquire MHC-II first, fol-
lowed by langerin expression. This is
similar in the newborn. Shortly after birth
and settlement in the epidermis, both
markers sequentially come up on LCs (re-
viewed in Romani et al., 2010). The time
course was protracted in the chimeric
mice (fewweeks after bonemarrow trans-
fer) as compared with newborn (few days
after birth). The authors then undertook
a set of experiments to dissect repopula-
tion during skin inflammation, and to this
end, they resorted to the UV model origi-
nally described by Merad et al., (2002).
UV-C irradiation led to inflammation in
the skin and to the loss of LCs from the
epidermis within 1 week. At the same
time, both epidermis and dermis were
strongly infiltrated by Gr-1+ monocytic
cells. Within the following 4 weeks, the
epidermis of WT mice was repopulated
by dendritic cells, which acquired MHC-II
and high langerin expression in a
sequential fashion, as it may have seemed
at first glance. Id2-deficient mice,
